|
|
 |
 | Medical News Releases > University Groups > School of Medicine >
Infectious Disease
| News Stories & Tip Sheets: |
Showing Stories 1 through 3 of 52.
- Show More |
|
Flu fight
Recovery act funds new flu drug discovery center at Washington University
Nov. 16,
2009 -- Scientists at the School of Medicine are investigating a new way to fight the flu. With funding from the American Recovery and Reinvestment Act, they will establish a Drug Discovery Center to identify compounds that enhance the body's natural virus-killing mechanisms to overcome the flu.
|
Take the test
Free, confidential HIV testing at WU's Infectious Diseases Clinic
Oct. 12,
2009 -- The School of Medicine's Infectious Diseases Clinic offers free, confidential HIV testing Monday through Friday. No appointment is necessary. Individuals will receive a rapid HIV test using a finger-prick blood sample, with results available 20 minutes after testing. Testing is offered Monday - Thursday from 9 a.m. to noon and from 1 - 3 p.m., and on Friday from 9 - 11 a.m. The clinic is located at 4570 Children's Place, on the medical school campus.
|
NIH extends biodefense funding
$37 million to extend regional biodefense and emerging infectious diseases research
June 24,
2009 -- The National Institutes of Health (NIH) has extended funding for the Midwest Regional Center for Excellence in Biodefense and Emerging Infectious Diseases (MRCE), anchored at the School of Medicine. The center received a five-year, $37 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) to continue to support basic and translational research in biodefense and emerging infectious diseases throughout the Midwest.
|
Showing Stories 1 through 3 of 52.
- Show More |
|
| Faculty Experts: |
Showing Experts 1 through 5 of 6.
- Show More |
|
Bradley P. Stoner
Associate Professor of Sociocultural Anthropology in Arts and Sciences
Dr. Stoner, who joined the Infectious Disease division in 1995, holds a joint appointment as Associate Professor of Anthropology in Arts & Sciences. He studied anthropology at Harvard University and McGill University, and received the M.D. and Ph.D. degrees from Indiana University. He completed residency ...
Expertise: anthropology, public health, medicine, sexually transmitted diseases, biomedicine, medical anthropology, anthropology of public health, …
Direct contact: (314) 935-5673
/
bstoner@wustl.edu
|
Richard Chole
Lindburg Professor and head of otolaryngology
Chole is known for developing the oto-endoscopic camera and a prosthetic device that functions as a replacement for middle ear bones damaged by injury or infection. His current research aims to understand the mechanisms which are operant in the pathophysiology of inflammatory osteolysis in the middle ...
Expertise: bacteriology, bone biology, inflammation, hearing, signal transduction
Media assistance: (314) 286-0141 / ericsong@wustl.edu
|
David Clifford
Melba and Forest Seay Professor of Clinical Neuropharmacology in Neurology
Clifford, who is director of the AIDS Clinical Trials Unit (ACTU) at Barnes-Jewish Hospital, is a leading expert on the neurological complications of AIDS and their treatment and management. He has also participated in studies of epilepsy, Parkinson's disease and multiple sclerosis. Clifford is involved ...
Expertise: Neuropharmacology, HIV, AIDS, AIDS-related dementia, peripheral neuropathy, leukoencephalopathy, progressive multifocal leukoencephalopathy, …
Media assistance: (314) 286-0126 / pattoner@wustl.edu
|
Samuel Stanley
Director of the Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research
 |
| Stanley |
Stanley directs the Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (MRCE), funded by a $35 million grant from the National Institute of Allergy and Infectious Diseases. The center's mission is to support basic and translational research in critical areas ...
Expertise: biodefense, infectious diseases
Media assistance: (314) 935-5217 / joeangeles@wustl.edu
|
Stephen Beverley
Marvin A. Brennecke Professor of Molecular Microbiology
Beverley is an international leader in the development of genetic and molecular tools for studying human parasites. He has put those innovations to use in extensive studies of Leismania major, a parasite that infects approximately 12 million people worldwide, causing significant death and disfigurement. ...
Expertise: Molecular genetics of protozoan parasites; genomics, virulence and drug resistance; leishmania, leishmaniasis
Media assistance: (314) 286-0122 / purdym@wustl.edu
|
Showing Experts 1 through 5 of 6.
- Show More |
|
| Related News Clips: |
Showing 5 Clips.
|
|
Study: Failed Genzyme drug may fight West Nile
Boston Globe
and 1 others
Aug. 5,
2008 -- A failed AIDS drug helped fight West Nile virus in mice, suggesting it might also work in humans against the brain-infecting malady for which there's no vaccine or cure, a WUSTL study showed.
The study led by WUSTL infectious diseases professor Robyn Klein was published in the Proceedings of the National Academy of Sciences.
|
Study Says Implants Double Risk of Infection After Breast Reconstructive Surgery
The New York Times
and 27 others
Jan. 22,
2008 -- More than one in 20 patients undergoing breast surgery later developed infections at incision sites, according to a new study, a complication that was more common than thought. Study co-authors WUSTL infectious diseases professor Margaret Olsen and WUSTL plastic and reconstructive surgery professor Keith Brandt comment.
|
Invasive Mosquito Species Found in Midwest
Washington Post, St. Louis Post-Dispatch
and 32 others
Sept. 27,
2005 -- A species of mosquito common in the eastern U.S. and capable of carrying the West Nile virus has made its way to the Midwest for the first time, a finding made by WUSTL junior chemistry major Stephanie Gallitano.
Gallitano, WUSTL biology professor Jonathan Chase and Gallitano's mentor and postdoctoral fellow James Vonesh comment.
|
A new approach to fighting flu
Philadelphia Inquirer
and 17 others
June 22,
2005 -- Article on a Philadelphia scientist who is working on a virulent Southeast Asian flu strain that is killing birds and threatens to start a flu pandemic. He is testing a prototype vaccine that could play a critical role in protecting people from the flu — especially against a lethal pandemic strain. Some experts believe it could lead to a long-lasting shot that might make annual flu clinics a thing of the past. WUSTL researcher Andrew Pekosz talks about the positive results his own team has had and said he hoped their vaccine would be ready for human trials in a year.
|
National Institutes of Health funds regional research center at Colorado State
Associated Press State & Local Wire
and 48 others
June 2,
2005 -- The NIH awarded a $40 million grant to Colorado State University for a regional center to fight animal-to-human diseases such as West Nile and hantavirus. The Rocky Mountain center will be one of 10 regional consortiums, including WUSTL, funded by the NIH to research threats from infectious diseases and bioterror agents.
|
Affiliated with Barnes-Jewish Hospital and St. Louis Children's Hospital, members of BJC HealthCare.
Please contact us and let us know how we can assist you.
Technical problems with this Web site? Email questions or comments.
Please review the WUSTL News & Information copyright/privacy policy.
| |
|
| | |
|
Print ready page